Research ArticleOriginal Research

Cardiovascular Screening and Lipid Management in Breast Cancer Survivors

S. Tucker Price, Lisa D. Mims, Marty S. Player, Carole Berini, Suzanne Perkins, Chanita Hughes Halbert and Vanessa A. Diaz
The Journal of the American Board of Family Medicine November 2020, 33 (6) 894-902; DOI: https://doi.org/10.3122/jabfm.2020.06.190459

References

  1. 1.↵
    1. Miller KD,
    2. Siegel RL,
    3. Lin CC,
    4. et al
    . Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 2016;66:271–89.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Maas AH,
    2. Ottevanger N,
    3. Atsma F,
    4. Cramer MJ,
    5. Leiner T,
    6. Poortmans P
    . Cardiovascular surveillance in breast cancer treatment: a more individualized approach is needed. Maturitas 2016;89:58–62.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Montazeri K,
    2. Unitt C,
    3. Foody JM,
    4. Harris JR,
    5. Partridge AH,
    6. Moslehi J
    . ABCDE steps to prevent heart disease in breast cancer survivors. Circulation 2014;130:e157–e159.
    OpenUrlFREE Full Text
  4. 4.↵
    1. Ording AG,
    2. Boffetta P,
    3. Garne JP,
    4. Witt Nyström PM,
    5. Cronin-Fenton D,
    6. Frøslev T,
    7. et al
    . Relative mortality rates from incident chronic diseases among breast cancer survivors—A 14 year follow-up of five-year survivors diagnosed in Denmark between 1994 and 2007. Eur J Cancer 2015;51:767–75.
    OpenUrl
  5. 5.↵
    1. Jordan JH,
    2. Thwin SS,
    3. Lash TL,
    4. Buist DSM,
    5. Field TS,
    6. Haque R,
    7. et al
    . Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study. Breast Cancer Res Treat 2014;146:401–9.
    OpenUrlPubMed
  6. 6.↵
    1. Jones DH,
    2. Nestore M,
    3. Henophy S,
    4. Cousin J,
    5. Comtois AS
    . Increased cardiovascular risk factors in breast cancer survivors identified by routine measurements of body composition, resting heart rate and arterial blood pressure. Springerplus 2014;3:150.
    OpenUrl
  7. 7.↵
    1. Jones LM,
    2. Stoner L,
    3. Brown C,
    4. Baldi C,
    5. McLaren B
    . Cardiovascular disease among breast cancer survivors: the call for a clinical vascular health toolbox. Breast Cancer Res Treat 2013;142:645–53.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Patnaik JL,
    2. Byers T,
    3. DiGuiseppi C,
    4. Dabelea D,
    5. Denberg TD
    . Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res 2011;13:R64.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Patnaik JL,
    2. Byers T,
    3. Diguiseppi C,
    4. Denberg TD,
    5. Dabelea D
    . The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 2011;103:1101–11.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Bradshaw PT,
    2. Stevens J,
    3. Khankari N,
    4. Teitelbaum SL,
    5. Neugut AI,
    6. Gammon MD
    . Cardiovascular disease mortality among breast cancer survivors. Epidemiology 2016;27:6–13.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Strongman H,
    2. Gadd S,
    3. Matthews A,
    4. et al
    . Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. Lancet 2019;21:1041–1054.
    OpenUrl
  12. 12.↵
    1. Barac A,
    2. Murtagh G,
    3. Carver JR,
    4. Chen MH,
    5. Freeman AM,
    6. Herrmann J,
    7. et al
    . Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level. J Am Coll Cardiol 2015;65:2739–46.
    OpenUrlFREE Full Text
  13. 13.↵
    1. Koene RJ,
    2. Prizment AE,
    3. Blaes A,
    4. Konety SH
    . Shared risk factors in cardiovascular disease and cancer. Circulation 2016;133:1104–14.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Wolf I,
    2. Sadetzki S,
    3. Catane R,
    4. Karasik A,
    5. Kaufman B
    . Diabetes mellitus and breast cancer. Lancet Oncol 2005;6:103–11.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Han H,
    2. Guo W,
    3. Shi W,
    4. Yu Y,
    5. Zhang Y,
    6. Ye X,
    7. et al
    . Hypertension and breast cancer risk: a systematic review and meta-analysis. Sci Rep 2017;7:44877.
    OpenUrlCrossRef
  16. 16.↵
    1. Lowenstein LM,
    2. Ouellet JA,
    3. Dale W,
    4. Fan L,
    5. Gupta Mohile S
    . Preventive care in older cancer survivors. J Geriatr Oncol 2015;6:85–92.
    OpenUrl
  17. 17.↵
    1. Lenihan DJ,
    2. Cardinale DM
    . Late cardiac effects of cancer treatment. J Clin Oncol 2012;30:3657–64.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Hooning MJ,
    2. Botma A,
    3. Aleman BM,
    4. Baaijens MHA,
    5. Bartelink H,
    6. Klijn JGM,
    7. et al
    . Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 2007;99:365–75.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Baxi SS,
    2. Pinheiro LC,
    3. Patil SM,
    4. Pfister DG,
    5. Oeffinger KC,
    6. Elkin EB
    . Causes of death in long-term survivors of head and neck cancer. Cancer 2014;120:1507–13.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Zagar TM,
    2. Cardinale DM,
    3. Marks LB
    . Breast cancer therapy-associated cardiovascular disease. Nat Rev Clin Oncol 2016;13:172–84.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Daher IN,
    2. Daigle TR,
    3. Bhatia N,
    4. Durand JB
    . The prevention of cardiovascular disease in cancer survivors. Tex Heart Inst J 2012;39:190–8.
    OpenUrlPubMed
  22. 22.↵
    1. Jones LW,
    2. Haykowsky MJ,
    3. Swartz JJ,
    4. Douglas PS,
    5. Mackey JR
    . Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol 2007;50:1435–41.
    OpenUrlFREE Full Text
  23. 23.↵
    1. Nathan PC,
    2. Amir E,
    3. Abdel-Qadir H
    . Cardiac outcomes in survivors of pediatric and adult cancers. Can J Cardiol 2016;32:871–80.
    OpenUrl
  24. 24.↵
    1. Kirkham AA,
    2. Virani SA,
    3. Campbell KL
    . The utility of cardiac stress testing for detection of cardiovascular disease in breast cancer survivors: a systematic review. Int J Womens Health 2015;7:127–40.
    OpenUrl
  25. 25.↵
    1. Chen J,
    2. Lu Y,
    3. Zheng Y
    . Incidence and risk of hypertension with bevacizumab in non–small-cell lung cancer patients: a meta-analysis of randomized controlled trials. Drug Des Devel Ther 2015;9:4751–60.
    OpenUrl
  26. 26.↵
    1. Chen CL
    . Cardiovascular prevention in the cancer survivor. Curr Atheroscler Rep 2015;17:484484. 25637040
    OpenUrlCrossRef
  27. 27.↵
    1. Bhatt DL
    . Ask the doctor. I had radiation and chemotherapy treatments for breast cancer. My cancer doctor sent me to a cardiologist for an ultrasound. Are there cardiac risks to cancer treatments? Harv Heart Lett 2014;25:2.
    OpenUrl
  28. 28.↵
    1. Kenyon M,
    2. Mayer DK,
    3. Owens AK
    . Late and long-term effects of breast cancer treatment and surveillance management for the general practitioner. J Obstet Gynecol Neonatal Nurs 2014;43:382–98.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Dossett LA,
    2. Hudson JN,
    3. Morris AM,
    4. et al
    . The primary care provider (PCP)-cancer specialist relationship: a systematic review and mixed-methods meta-synthesis. CA Cancer J Clin 2017;67:156–69.
    OpenUrlPubMed
  30. 30.↵
    1. Cheung WY,
    2. Neville BA,
    3. Cameron DB,
    4. Cook EF,
    5. Earle CC
    . Comparisons. of patient and physician expectations for cancer survivorship care. J Clin Oncol 2009;27:2489–95.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Klabunde CN,
    2. Ambs A,
    3. Keating NL,
    4. Doucette WR,
    5. Tisnado D,
    6. Clauser S,
    7. et al
    . The role of primary care physicians in cancer care. J Gen Intern Med 2009;24:1029–36.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Mayer DK,
    2. Nasso SF,
    3. Earp JA
    . Defining cancer survivors, their needs, and perspectives on survivorship health care in the USA. Lancet Oncol 2017;18:e11–e8.
    OpenUrl
  33. 33.↵
    1. Lawrence RA,
    2. McLoone JK,
    3. Wakefield CE,
    4. Cohn RJ
    . Primary care physicians' perspectives of their role in cancer care: a systematic review. J Gen Intern Med 2016;31:1222–36.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Nekhlyudov L
    . “Doc, should I see you or my oncologist?”: a primary care perspective on opportunities and challenges in providing comprehensive care for cancer survivors. J Clin Oncol 2009;27:2424–6.
    OpenUrlFREE Full Text
  35. 35.↵
    1. Nekhlyudov L
    . Integrating primary care in cancer survivorship programs: models of care for a growing patient population. Oncologist 2014;19:579–82.
    OpenUrlFREE Full Text
  36. 36.↵
    1. Rubin G,
    2. Berendsen A,
    3. Crawford SM,
    4. et al
    . The expanding role of primary care in cancer control. Lancet Oncol 2015;16:1231–72.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Mandelzweig L,
    2. Chetrit A,
    3. Amitai T,
    4. Silverman B,
    5. Siegelmann-Danieli N,
    6. Sadetzki S
    . Primary prevention and screening practices among long-term breast cancer survivors. Cancer Causes Control 2017;28:657–66.
    OpenUrl
  38. 38.↵
    1. Snyder CF,
    2. Frick KD,
    3. Herbert RJ,
    4. Blackford AL,
    5. Neville BA,
    6. Lemke KW,
    7. et al
    . Comorbid condition care quality in cancer survivors: role of primary care and specialty providers and care coordination. J Cancer Surviv 2015;9:641–9.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Earle CC,
    2. Burstein HJ,
    3. Winer EP,
    4. Weeks JC
    . Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol 2003;21:1447–51.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Chidwick K,
    2. Strongman H,
    3. Matthews A,
    4. Stanway S,
    5. Lyon AR,
    6. Smeeth L,
    7. et al
    . Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK clinical practice research datalink. BMC Cancer 2018;18:1018.
    OpenUrl
  41. 41.↵
    1. Lewallen S,
    2. Courtright P
    . Epidemiology in practice: case-control studies. Community Eye Health 1998;11:57–8.
    OpenUrlPubMed
  42. 42.↵
    1. James PA,
    2. Oparil S,
    3. Carter BL,
    4. et al
    . 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507–20.
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    1. Stone NJ,
    2. Robinson JG,
    3. Lichtenstein A
    . The new cholesterol treatment guidelines. N Engl J Med 2014;370:1957.
    OpenUrl
  44. 44.↵
    1. Armstrong C
    . JNC8 guidelines for the management of hypertension in adults. Am Fam Physician 2014;90:503–4.
    OpenUrlPubMed
  45. 45.↵
    1. Mehta LS,
    2. Watson KE,
    3. Barac A,
    4. Beckie TM,
    5. Bittner V,
    6. Cruz-Flores S,
    7. et al
    . Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation 2018;137:e30–e66.
    OpenUrlAbstract/FREE Full Text
  46. 46.↵
    1. Yeo W,
    2. Mo FKF,
    3. Pang E,
    4. Suen JJS,
    5. Koh J,
    6. Loong HHF,
    7. et al
    . Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy. BMC Womens Health 2017;17:55.
    OpenUrl
  47. 47.↵
    1. Blaes A,
    2. Beckwith H,
    3. Florea N,
    4. Hebbel R,
    5. Solovey A,
    6. Potter D,
    7. et al
    . Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study. Breast Cancer Res Treat 2017;166:541–7.
    OpenUrl
  48. 48.↵
    1. Snyder CF,
    2. Frick KD,
    3. Kantsiper ME,
    4. Peairs KS,
    5. Herbert RJ,
    6. Blackford AL,
    7. et al
    . Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol 2009;27:1054–61.
    OpenUrlAbstract/FREE Full Text
  49. 49.↵
    1. Snyder CF,
    2. Frick KD,
    3. Peairs KS,
    4. Kantsiper ME,
    5. Herbert RJ,
    6. Blackford AL,
    7. et al
    . Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med 2009;24:469–74.
    OpenUrlCrossRefPubMed
  50. 50.↵
    1. Snyder CF,
    2. Frick KD,
    3. Herbert RJ,
    4. Blackford AL,
    5. Neville BA,
    6. Wolff AC,
    7. et al
    . Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls. J Clin Oncol 2013;31:1140–8.
    OpenUrlAbstract/FREE Full Text
  51. 51.↵
    1. Yedjou CG,
    2. Tchounwou PB,
    3. Payton M,
    4. Fonseca DD,
    5. Lowe L,
    6. Alo RA
    . Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United States. Int J Environ Res Public Health 2017;14:486.
    OpenUrl
  52. 52.↵
    1. Tangka FKL,
    2. Subramanian S
    . Importance of implementation economics for program planning-evaluation of CDC’s colorectal cancer control program. Eval Program Plann 2017;62:64–6.
    OpenUrl
  53. 53.↵
    1. Bibbins-Domingo K,
    2. Grossman DC,
    3. Curry SJ Jr.,
    4. Davidson KW,
    5. Epling JW Jr.,
    6. García FAR,
    7. et al
    . Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement. JAMA 2016;316:1997–2007.
    OpenUrlCrossRefPubMed
  54. 54.↵
    1. Stewart JH,
    2. Bertoni AG,
    3. Staten JL,
    4. Levine EA,
    5. Gross CP
    . Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol 2007;14:3328–34.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords